Reem Alsolami

Jeddah, 21589, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Computational Design and Optimization of Peptide Inhibitors for SIRT2.

Computational Design and Optimization of Peptide Inhibitors for SIRT2.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 10, 2024

Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells.

Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells.

Journal: PloS one

Published: June 28, 2024

Acute and prolonged effects of interleukin-33 on cytokines in human cord blood-derived mast cells.

Acute and prolonged effects of interleukin-33 on cytokines in human cord blood-derived mast cells.

Journal: Immunology letters

Published: May 02, 2024

Gene expression profiling on CML patients with Philadelphia translocation.

Gene expression profiling on CML patients with Philadelphia translocation.

Journal: European review for medical and pharmacological sciences

Published: March 04, 2024

Correction: Jamal et al. Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells. Nanomaterials 2022, 12, 4029.

Correction: Jamal et al. Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells. Nanomaterials 2022, 12, 4029.

Journal: Nanomaterials (Basel, Switzerland)

Published: February 06, 2024

Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies.

Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies.

Journal: International journal of general medicine

Published: August 27, 2023

Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells.

Preparation of 6-Mercaptopurine Loaded Liposomal Formulation for Enhanced Cytotoxic Response in Cancer Cells.

Journal: Nanomaterials (Basel, Switzerland)

Published: November 02, 2022

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Journal: Nature genetics

Published: April 30, 2021

Correction: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Correction: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Journal: Leukemia

Published: July 19, 2019

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Journal: Leukemia

Published: November 22, 2017

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.

Journal: Leukemia

Published: January 09, 2017

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Journal: Leukemia

Published: November 02, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026